• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术治疗难治性腹水:左心室舒张功能障碍的临床影响。

Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.

机构信息

Division of Gastroenterology.

Cardiology Unit.

出版信息

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e464-e470. doi: 10.1097/MEG.0000000000002151.

DOI:10.1097/MEG.0000000000002151
PMID:33867443
Abstract

BACKGROUND AND AIMS

Left ventricular diastolic dysfunction (LVDD) in cirrhotics are associated with circulatory dysfunction, hepatorenal syndrome (HRS) and heart failure in stressful conditions. Transjugular intrahepatic portosystemic shunt (TIPS) exacerbates the hyperdynamic circulation and challenges cardiac function. We evaluated the incidence and the impact of LVDD in cirrhotic candidates to TIPS for refractory ascites.

METHODS

Among 135 patients who underwent TIPS for refractory ascites, 63 cases (child B/C 53/10, Na-model for end-stage liver disease 16.5 ± 0.9) who had 2D-transthoracic-echocardiography with tissue-Doppler-imaging pre-TIPS were retrospectively analysed (group A); in 23 cases cardiac and hormonal assessment before and after TIPS was available. 41 cirrhotics without refractory ascites treated by banding ligation for variceal re-bleeding were used as controls (group B).

RESULTS

The prevalence of LVDD was higher in group A (59%; 22% with grade ≥2) as compared to group B (35%; 7% with grade ≥2) (P < 0.01 and P < 0.03). A lack of clinical response to TIPS occurred in 10 patients, all with LVDD (P < 0.03 vs. no LVDD) and in patients with grade ≥2 LVDD mostly (P < 0.02 vs. grade 1). Central venous pressure >20 mmHg after TIPS and left ventricular end-diastolic volume at basal were predictors of no response to TIPS (P = 0.01 and P = 0.004, respectively), which was an independent predictor of death. Elevated levels of NT-proBNP 3 days after TIPS were associated with advanced cardiac dysfunction (P = 0.005).

CONCLUSION

NT-proBNP and careful LVDD investigation are useful to better select patients and to predict clinical response and mortality after TIPS.

摘要

背景和目的

肝硬化患者的左心室舒张功能障碍(LVDD)与循环功能障碍、肝肾综合征(HRS)和应激条件下的心衰有关。经颈静脉肝内门体分流术(TIPS)加重了高动力循环,并对心脏功能构成挑战。我们评估了 TIPS 治疗难治性腹水的肝硬化患者中 LVDD 的发生率和影响。

方法

在 135 例因难治性腹水而行 TIPS 的患者中,回顾性分析了 63 例(Child-Pugh B/C 53/10,终末期肝病模型 16.5±0.9)在 TIPS 前进行 2D 经胸超声心动图和组织多普勒成像的患者(A 组);在 23 例患者中,TIPS 前后的心脏和激素评估是可用的。41 例因静脉曲张再出血而行套扎结扎治疗的肝硬化患者作为对照(B 组)。

结果

A 组 LVDD 的患病率高于 B 组(59%;22%为 2 级以上)(P<0.01 和 P<0.03)。10 例患者对 TIPS 无临床反应,均有 LVDD(P<0.03 与无 LVDD),且大多数为 2 级以上 LVDD(P<0.02 与 1 级)。TIPS 后中心静脉压>20mmHg 和基础左心室舒张末期容积是对 TIPS 无反应的预测因素(P=0.01 和 P=0.004),这是死亡的独立预测因素。TIPS 后 3 天 NT-proBNP 水平升高与晚期心脏功能障碍有关(P=0.005)。

结论

NT-proBNP 和仔细的 LVDD 调查有助于更好地选择患者,并预测 TIPS 后的临床反应和死亡率。

相似文献

1
Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.经颈静脉肝内门体分流术治疗难治性腹水:左心室舒张功能障碍的临床影响。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e464-e470. doi: 10.1097/MEG.0000000000002151.
2
Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction.难治性腹水患者对容量扩张和经颈静脉肝内门体分流术的循环反应:与舒张功能障碍的关系
Dig Liver Dis. 2015 Dec;47(12):1052-8. doi: 10.1016/j.dld.2015.08.014. Epub 2015 Sep 3.
3
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
4
Diagnosis and Management of Cirrhotic Cardiomyopathy.肝硬化性心肌病的诊断与管理
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.
5
Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt.左心房功能障碍是经颈静脉肝内门体分流术治疗的肝硬化患者死亡率的独立预测因子。
Hepatol Commun. 2022 Nov;6(11):3163-3174. doi: 10.1002/hep4.2062. Epub 2022 Aug 27.
6
Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.经颈静脉肝内门体分流术治疗难治性腹水和静脉曲张出血的决策:MELD,还是不 MELD,这是个问题。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e214-e222. doi: 10.1097/MEG.0000000000002009.
7
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan.首报 4 例肝硬化腹水对托伐普坦抵抗患者经颈静脉肝内门体分流术的临床疗效。
BMJ Open Gastroenterol. 2023 Apr;10(1). doi: 10.1136/bmjgast-2023-001120.
8
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.经颈静脉肝内门体分流术治疗顽固性腹水:单中心经验
Scand J Gastroenterol. 2012 Dec;47(12):1494-500. doi: 10.3109/00365521.2012.703239. Epub 2012 Sep 10.
9
The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.使用E/A比值作为经颈静脉肝内门体分流术治疗的肝硬化患者预后的预测指标。
Am J Gastroenterol. 2009 Oct;104(10):2458-66. doi: 10.1038/ajg.2009.321. Epub 2009 Jun 16.
10
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水:经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.

引用本文的文献

1
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术后的心血管风险评估及心脏失代偿的预测因素
World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740.
2
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.舒张功能障碍与肝硬化患者经颈静脉肝内门体分流术后心脏失代偿有关。
United European Gastroenterol J. 2023 Nov;11(9):837-851. doi: 10.1002/ueg2.12471. Epub 2023 Oct 28.
3
Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria: alterations in ultrasonographic parameters of both left and right ventricles before and after stress.
根据不同诊断标准的肝硬化心肌病患病率:应激前后左、右心室超声参数的改变
Ann Gastroenterol. 2023 Sep-Oct;36(5):564-572. doi: 10.20524/aog.2023.0824. Epub 2023 Jul 20.
4
Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt.经颈静脉肝内门体分流术候选患者右心-肺循环单元的血流动力学评估
J Clin Med. 2022 Jan 17;11(2):461. doi: 10.3390/jcm11020461.